Associations Between Cancer and COVID-19 Death “More Substantial” in Women
The risk of in-hospital death from COVID-19 for patients with cancer differs by sex and cancer type, according to a new study.
The risk of in-hospital death from COVID-19 for patients with cancer differs by sex and cancer type, according to a new study.
Occupational exposure to the solvents benzene, toluene, and zylene can increase the risk of bladder cancer, a new study suggests.
A real-world study shows modest uptake of avelumab maintenance following its approval for advanced or metastatic urothelial carcinoma.
Cardiovascular disease (CVD), particularly atherosclerotic CVD, is associated with an increased risk of multiple cancers, research suggests.
After the BCG shortage began, patients with non-muscle invasive bladder cancer were less likely to receive a full course of induction with any drug.
Sequential treatment with BCG and mitomycin C appears effective in patients with high-risk nonmuscle-invasive bladder cancer.
The FDA has granted accelerated approval to Padcev with Keytruda for locally advanced or metastatic urothelial cancer.
The conversion from accelerated approval to regular approval was based on data from the KEYNOTE-158 trial, the KEYNOTE-164 trial, and the KEYNOTE-051 trial.
The median survival for patients with metastatic bladder cancer is increasing, possibly due to increasing use of immunotherapy.
The rising cost of care is having a negative impact on patients with bladder cancer, but a value-based approach to care might provide some relief.